RxSight's 15min chart triggers MACD and KDJ Death Crosses.

The 15-minute chart for RxSight has recently experienced a significant downturn, as evidenced by the occurrence of a MACD Death Cross and a KDJ Death Cross on September 19, 2025 at 09:45. This suggests that the stock price is poised to continue its downward trajectory, with a momentum shift towards the downside and a potential for further depreciation.

RxSight Inc. (NASDAQ: RXST) has experienced a significant downturn in its stock price, as indicated by the occurrence of a MACD Death Cross and a KDJ Death Cross on September 19, 2025, at 09:45. These technical indicators suggest a momentum shift towards the downside, potentially signaling further depreciation of the stock price.

On July 8, 2025, after the market closed, RxSight reported preliminary second quarter 2025 financial results, revealing significant declines in LDD sales, LAL utilization, and overall revenue. The company also lowered its full year 2025 guidance by approximately $42.5 million at the midpoint. The Company's Chief Executive Officer, Ronald Kurtz, disclosed that "adoption challenges over the last few quarters have been a primary reason for the LDD stall." This news led to a substantial drop in the stock price, falling $4.84, or 37.8%, to close at $7.95 per share on July 9, 2025, on unusually heavy trading volume Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit^[1].

The recent technical indicators, combined with the company's financial performance, have raised concerns among investors. The MACD Death Cross and KDJ Death Cross are strong signals of a trend reversal, often indicating a potential downturn in stock prices. As these indicators suggest a momentum shift towards the downside, investors should closely monitor RxSight's stock price and financial health.

Investors who purchased or otherwise acquired RxSight securities between May 7, 2024, and July 8, 2025, may be eligible to participate in a class action lawsuit. The deadline to file a lead plaintiff motion in this class action is September 22, 2025 Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit^[1]. Law firms such as Glancy Prongay & Murray LLP and Faruqi & Faruqi, LLP are encouraging investors who suffered losses to contact them for more information and potential legal recourse Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit^[1]Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight^[2].